Natural Product Research · 2012 · 44 citations · 18 references
Life SciencesBiochemistryMicrobiologyDrug DiscoveryMycologyStructure-activity RelationshipsAntifungal AgentsFungal BiochemistryFungal Secondary MetabolitesMedicinal PlantsMetabolite IdentificationAntimicrobial MetabolitesBioactive Fungal MetabolitesCandida Albicans InfectionFungal Bioactive CompoundsNatural Antifungal CompoundsSecondary MetabolitesStructural Elucidation From SpectraStructure Elucidation Of Fungal Metabolites
Ethyl acetate extracts of Armillaria tabescens (strain JNB-OZ344) showed significant fungistatic and bacteristatic activities against several major human pathogens including Candida albicans, Cryptococcus neoformans, Escherichia coli and Mycobacterium intracellulare. Chemical analysis of these extracts led to the isolation and identification of four new compounds, emestrin-F (1), emestrin-G (2), 6-O-(4-O-methyl-β-D-glucopyranosyl)-8-hydroxy-2,7-dimethyl-4H-benzopyran-4-one (3) and cephalosporolide-J (4), along with five other previously known compounds, emestrin (5), cephalosporolide-E (6), decarestrictine-C2 (7), ergosterol and brassicasterol. Structural elucidation of all compounds was carried out by NMR and MS analyses. Antimicrobial assays revealed that compounds 1 and 5 were responsible for the observed growth inhibitory activities of the fungal extracts against the human pathogens tested.
18
Natural Product Communications
Natural Product Communications · 2018 · 656 citations · Full text
Susanne Grabley, Peter Hammann, Klaus Hütter et al. · The Journal of Antibiotics · 1992 · 112 citations · Full text